CABA · NASDAQ · Biotechnology

Cabaletta Bio (CABA)

Develops engineered T-cell therapies for autoimmune disease, prioritizing rese-cel.

$2.50
After hours+0.00 (+0.20%)
At close$2.50(+1.42%)